About us
Research Library
Company Pages
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
Redx Pharma
Scancell
Contact us
More Company News
Avacta
H123 interim results
28 Sep 2023
Read More
Avacta
Completion of AVA6000 sixth dose escalation and clinical update
19 Sep 2023
Read More
Avacta
Completion of fifth dose escalation of AVA6000
21 Jun 2023
Read More
Avacta
Second milestone in AffyXell JV
05 Jun 2023
Read More
Avacta
Aquisition of Coris Bioconcept
01 Jun 2023
Read More
Avacta
First patient dosed in the US in AVA6000 Phase I study
27 Apr 2023
Read More
Avacta
FY22 results
25 Apr 2023
Read More
Avacta
AVA3996 data poster presented at AACR
17 Apr 2023
Read More
Avacta
First US clinical investigator AVA6000 sites opened
06 Apr 2023
Read More
Avacta
First patient dosed in fifth cohort of AVA6000 Phase I study
05 Apr 2023
Read More
1
2
3
4
5
Return to Avacta
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About us
Research Library
Company Pages
â–¼
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
Redx Pharma
Scancell
Contact us